Life Sciences Advisory Bulletin
U.S.
Patent Office Announces Pilot Program
for Pre-Appeal Brief Conferences
A
Brand New Opportunity to “Test the Waters” Quickly Before
Appealing a Final Rejection of a Patent Application to the Board
By Jane
E.R. Potter, Ph.D.
Published by DWT's
Patents Practice Group
[August 2005]
When claims have been rejected twice
in a patent application, the applicant can appeal the Examiner’s
rejections to the Board of Patent Appeals and Interferences. Before
preparing and filing an Appeal Brief, it would be helpful, however,
if the applicant could find out quickly (and at less expense) just
how strong their position is in relation to the Examiner’s
grounds of rejection. A new program at the U.S. Patent and Trademark
Office provides just such an opportunity. The Patent Office recently
began a pilot program which allows applicants to obtain a Pre-Appeal
Brief Review of the arguments that they would present in
their Appeal Brief.
Standard Appeal Process
After a patent application is filed
in the U. S. Patent and Trademark Office, the patent applicant may
receive an Office Action in which an Examiner has rejected some
or all of the claims of the patent application. The applicant can
file a response to the Office Action, and if the claims remain rejected
on substantive grounds, such as prior art or lack of enablement,
the Examiner will issue another Office Action. This Office Action
may be designated as “Final,” which limits the options
open to the applicant.
Following receipt of the Final Office Action, one
option is to file another response, with the goal of amending the
claims or submitting arguments to put the claims in condition for
allowance. A second option is to file a continuation application
to pursue similar or other subject matter. A third option is to
appeal the Examiner’s decision to the Board of Patent Appeals
and Interferences. (This appeal may also be taken if the second
Office Action is non-final, but the claims have been rejected twice.)
However, the appeal process is likely to involve the preparation
of detailed arguments, and there can be a delay of months or years
before the case is decided by the Board. Furthermore, the applicant
may not have raised all possible issues during prosecution before
the Examiner, and “new” arguments or evidence cannot
by asserted for the first time in the Appeal Brief.
About the New Pilot Program
The stated goals of the new Pre-Appeal Brief Conference
Pilot Program are (a) to identify clearly improper rejections based
on error(s) of fact, and (b) to identify whether the essential elements
exist to support the rejection. To take advantage of the program,
the applicant must submit a “Pre-Appeal Brief Request
for Review,” using the one-page form available from the
Patent Office (Form
PTO/SB/33), and must submit a “succinct, concise and focused”
set of arguments. The Arguments section must be five pages
or less. The Arguments should specify the alleged clear
errors in the Examiner’s rejections, or the Examiner’s
omissions of one or more essential elements for a prima facie
rejection. Importantly, the Request and the Arguments must be filed
with the Notice of Appeal.
A panel of Examiners experienced in the appropriate
area of technology will review the Arguments and the Examiner’s
rejections. The panel will include the Examiner of record in the
application under consideration. Unlike a full appeal to the Board,
the applicant will not be permitted to attend the review, and no
interviews will be granted prior to issuance of the panel’s
decision. The goal of the program is to mail a copy of the panel’s
decision to the applicant within 45 days of receipt
of the properly filed request.
The panel’s decision will contain one of the following findings:
Finding 1: The application remains under
appeal because there is at least one actual issue for appeal.
(Under this finding, the applicant can file an Appeal Brief using
the regular procedures.)
Finding 2: Prosecution on the merits is
reopened and the application is returned to the Examiner. The
panel may a propose an amendment that would place the application
in condition for allowance.
Finding 3: The application is allowed on
the existing claims.
Finding 4: The request fails to comply
with the submission requirements and is dismissed.
The Pilot Program for Pre-Appeal Brief Conferences
is scheduled to run for at least six months, at which time the effectiveness
will be evaluated. Additional details on the pilot program are published
in the Official Gazette of July 12, 2005.
Although this is a new and untried option at this
point, it does provide applicants with an opportunity to frame their
position prior to filing an Appeal Brief, and to get a quick evaluation
of this position. This option will be particularly useful if the
applicant believes that the Examiner has made a clear error in rejecting
the claims, or that the Examiner has not presented a prima facie
rejection. As the Patent Office is providing for a 45-day time limit
on mailing the panel’s decision to the applicant, this new
procedure will not unduly delay the filing of an Appeal Brief, if
applicant decides to take that route, or filing a continuation application
should review of the panel's decision suggest that route is more
appropriate.
After the initial six months, the pilot program may
become part of Patent Office procedures, it may be modified, or
it may not be continued. Thus, for cases in which a patent application
is now under final or second rejection and you are considering filing
an Appeal to the Board, it may provide a good opportunity to obtain
feedback from experienced Examiners. It is also an opportunity to
provide the Patent Office with your input on whether this is a program
worth keeping. A significant number of cases are allowed or returned
to the Examiner for further action after an applicant files an Appeal
Brief, and this may be a new and faster way of reaching that result
without the time and expense of the full Appeal process.
For further information, please contact:
This Life Sciences Advisory Bulletin is a publication of the Life
Sciences Group of Davis Wright Tremaine LLP. Our purpose in publishing
this Advisory Bulletin is to inform our clients and friends of developments
in life sciences law. It is not intended, nor should it be used,
as a substitute for specific legal advice as legal counsel may be
given only in response to inquiries regarding particular situations.
Copyright © 2005, Davis
Wright Tremaine LLP.
return to Advisory Bulletins main page
|
